Japan 3D Bioprinting Market Expected to Reach USD 316.7 Million by 2033 - IMARC Group

February 14, 2025 | Technology & Media

Japan 3D Bioprinting Market Statistics, Outlook and Regional Analysis 2025-2033

The Japan 3D bioprinting market size was valued at USD 82.9 Million in 2024, and it is expected to reach USD 316.7 Million by 2033, exhibiting a growth rate (CAGR) of 16.1% from 2025 to 2033.

Japan 3D Bioprinting Market

To get more information on this market, Request Sample

Japan's aging demographic is inflating the requirement for advanced healthcare solutions, particularly in areas like organ replacement, tissue regeneration, and personalized therapies. For instance, the elderly population aged 65 and above in Japan surpassed 30 million in 2024. Bioprinting provides innovative solutions for age-related health issues, thereby fueling its growth within the pharmaceutical sector. Additionally, Japan’s 3D bioprinting market is supported by the escalating demand for advanced manufacturing technologies in the healthcare and F&B industries.

Innovations in bioprinting techniques are enabling the development of customized tissues, organ models, and even edible products like cultured meat. They aid in enhancing precision, sustainability, and personalization in production processes. In March 2024, Osaka University, Shimadzu, Itoham Yonekyu, Toppan, and SIGMAXYZ formed a consortium to advance 3D bioprinting for edible cultured meat. The group focuses on developing bioprinting technology, establishing a production-to-logistics value chain, and collaborating with government and industry to shape legislation. They plan to showcase their efforts at the 2025 World Expo in Osaka.

Japan 3D Bioprinting Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include Kanto region, Kansai/Kinki region, Central/ Chubu region, Kyushu-Okinawa region, Tohoku region, Chugoku region, Hokkaido region, and Shikoku region. The escalating need for cancer therapeutics, along with the elevating adoption of regenerative medicines, is expanding the market.

Kanto Region 3D Bioprinting Market Trends:

In the Kanto region, Cyfuse Biomedical, based in Tokyo, created the Kenzan method, a scaffold-free 3D bioprinting technology that allows for exact tissue creation. This technique was used to evaluate drugs on liver tissue models. Also, the University of Tokyo collaborates on vascularized organ bioprinting. Besides this, various companies across this region, like Riken and Toppan invest in biomaterials, further driving the market expansion.

Kansai/Kinki Region 3D Bioprinting Market Trends:

Kyoto University in the Kansai/Kinki region has 3D-printed nerve conduits, proving their potential to regenerate peripheral nerves in animal models. At the same time, Osaka University has enhanced cardiac repair by generating functional heart tissue with bioprinting technology. Besides this, the Kobe biomedical cluster is also promoting drug screening advancements through bioprinting applications.

Central/Chubu Region 3D Bioprinting Market Trends:

Nagoya University in the Central/Chugoku region is working on 3D bioprinting to improve bone regeneration, developing scaffolds that support orthopedic treatments. In line with this, at Toyohashi University of Technology, researchers are exploring cartilage bioprinting to enhance joint repair. Besides this, in Aichi, various biotech companies are investing in dental bioprinting, aiming to create customized implants.

Kyushu-Okinawa Region 3D Bioprinting Market Trends:

Kyushu University is making significant progress in liver tissue bioprinting for drug testing and regenerative medicine, which is driving the market expansion. Besides this, Okinawa Institute of Science and Technology specializes in hydrogels for soft tissue engineering. Moreover, various companies across this region use 3D bioprinting and organ-on-a-chip technology to enhance pharmaceutical testing.

Tohoku Region 3D Bioprinting Market Trends:

Various key universities across the Tohoku region are focusing on neural tissue bioprinting to treat neurodegenerative illnesses. For instance, Fukushima Medical University creates 3D-printed spinal cord grafts for paralysis rehabilitation. Besides this, Akita's biotech sector is investigating bio-inks that enhance neuron regeneration, further bolstering the market.

Chugoku Region 3D Bioprinting Market Trends:

Researchers across the Chugoku region are developing bio-printed skin grafts to improve treatments for burns and wounds, aiming to enhance healing. Scientists at Okayama University are developing 3D-printed corneal tissue to help patients with eye injuries or disorders regain their vision. At the same time, biotech companies in the region are developing bio-ink creations that can help in epithelium regeneration.

Hokkaido Region 3D Bioprinting Market Trends:

Hokkaido University is focusing on the advancement of vascularized tissue bioprinting to improve graft survival, which is driving the market expansion in the Hokkaido region. The region’s strength in cryopreservation supports progress in bio fabrication. Besides this, various companies across the region are developing bio-printed blood vessels for organ transplants.

Shikoku Region 3D Bioprinting Market Trends:

Shikoku region, known for traditional herbal medicine, is exploring 3D bioprinting for personalized Kampo-based treatments. Various universities in Tokushima University are developing bio-print hydrogel-infused herbal scaffolds for controlled drug release. Also, various pharmaceutical companies in Kagawa are integrating bioprinting with plant-derived bioactive compounds for regenerative applications.

Top Companies Leading in the Japan 3D Bioprinting Industry

Key players across the country are investing in introducing novel methods, thereby elevating the market. In July 2024, scientists at the University of Tokyo developed a method to attach living skin to robots by using 3D printing. Furthermore, in January 2025, Roland DG unveiled a ceramic 3D printing technology at TCT Japan with complex structures.

Japan 3D Bioprinting Market Segmentation Coverage

  • On the basis of the component, the market has been bifurcated into 3D bioprinters (syringe/extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others), scaffolds, and biomaterials (living cells, hydrogels, extracellular matrices, and others). 3D bioprinters enable precise layer-by-layer printing of biological structures. Moreover, these components provide support for cell growth and tissue formation. Apart from this, innovations in R&D activities will continue to propel the market in the coming years.
  • Based on the application, the market has been bifurcated into research (drug research, regenerative medicine, and 3D cell culture) and clinical (skin, bone and cartilage, blood vessels, and others). 3D bioprinting is utilized in research for creating tissue models, studying diseases, and drug testing. Moreover, in clinical applications, 3D bioprinting focuses on developing personalized tissues and organs for treatments.
  • On the basis of the end user, the market has been bifurcated into hospitals, research organization and academic institutes, and biopharmaceutical companies. Hospitals use bioprinting for personalized treatments and tissue regeneration. Moreover, research organizations and academic institutes focus on advancing biomedical studies, while biopharmaceutical companies leverage the technology for drug development.

 

Report Features Details
Market Size in 2024 USD 82.9 Million
Market Forecast in 2033 USD 316.7 Million
Market Growth Rate 2025-2033 16.1%
Units Million USD
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Component
  • Application
  • End User
  • Region
Components Covered
  • 3D Bioprinters: Syringe/Extrusion Bioprinting, Inkjet Bioprinting, Magnetic Levitation Bioprinting, Laser-assisted Bioprinting, Others
  • Scaffolds
  • Biomaterials: Living Cells, Hydrogels, Extracellular Matrices, Others
Applications Covered
  • Research: Drug Research, Regenerative Medicine, 3D Cell Culture
  • Clinical: Skin, Bone and Cartilage, Blood Vessels, Others
End Users Covered Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies
Regions Covered Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Browse IMARC Related Reports on 3D Bioprinting Market:

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Japan 3D Bioprinting Market Expected to Reach USD 316.7 Million by 2033 - IMARC Group
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials